ARTEMIS: 192-week efficacy and safety of once-daily darunavir/ritonavir (DRV/r) vs lopinavir/r (LPV/r) in treatment-naïve HIV-1-infected adults
暂无分享,去创建一个
C. Orkin | T. van de Casteele | E. Dejesus | H. Khanlou | K. Supparatpinyo | A. Stoehr | S. Spinosa‐Guzman | E. Lathouwers